Active Ingredient (Per Inhaler)
Levmetamfetamine 50 mg
The following Structured Product Label (SPL) was submitted to the FDA by C.d.m.a., Inc. for the product Vapor Inhaler (NDC 63868-267). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (per inhaler), purpose, use for temporary relief of nasal congestion due to:, warnings, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Levmetamfetamine 50 mg
Nasal decongestant
symptoms persist
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center right away.
| adults and children 12 years of age and over | 2 inhalations in each nostril |
children 6 to under 12 years of age (with adult supervision) | 1 inhalation in each nostril |
| children under 6 years of age | ask a doctor |
| children under 2 years of age | do not use |
bornyl acetate, camphor, lavender oil, menthol, methyl salicylate
QC®
Quality Choice
NDC 63868-267-01
Vapor Inhaler
Nasal Decongestant
Levmetamfetamine | Nasal Decongestant
Temporary Relief of
Nasal Congestion due to:
Colds | Hay Fever
Upper Respiratory Allergies
*Compare to the active ingredient in Vicks®
Vapoinhaler
NET WT .007 oz (198 mg)
* Please review the disclaimer below.